BioXcel Therapeutics, Inc.
Recent Filings
All 638 filings →| Form | Description | Date |
|---|---|---|
| S-8 | FORM S-8 | Mar 27, 2026 |
| 10-K | 10-K | Mar 27, 2026 |
| 8-K | FORM 8-K | Mar 27, 2026 |
| 4 | OWNERSHIP DOCUMENT | Mar 16, 2026 |
| 4 | OWNERSHIP DOCUMENT | Mar 16, 2026 |
| 4 | OWNERSHIP DOCUMENT | Mar 16, 2026 |
| 4 | OWNERSHIP DOCUMENT | Mar 16, 2026 |
| 8-K | FORM 8-K | Mar 11, 2026 |
| 424B5 | 424B5 | Mar 11, 2026 |
| 8-K | FORM 8-K | Feb 12, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Mehta Vimal | CEO and President | Award / Grant | 15,625 | 20,111 | Jul 22, 2025 |
| Yocca Frank | Chief Scientific Officer | Award / Grant | 4,375 | 6,316 | Jul 22, 2025 |
| Rodriguez Javier | See Remarks | Award / Grant | 4,375 | 6,034 | Jul 22, 2025 |
| Steinhart Richard I | Chief Financial Officer | Sale | 372 @ $0.36 | 20,932 | Dec 15, 2024 |
| Yocca Frank | Chief Scientific Officer | Sale | 225 @ $0.35 | 28,931 | Dec 14, 2024 |
| Rodriguez Javier | See Remarks | Award / Grant | 21,250 | 30,633 | Oct 3, 2024 |
| Steinhart Richard I | Chief Financial Officer | Award / Grant | 21,250 | 27,454 | Oct 3, 2024 |
| Wiley Matthew T. | Chief Commercial Officer | Sale | 6,272 @ $0.55 | 19,011 | Sep 17, 2024 |
| Yocca Frank | Chief Scientific Officer | Sale | 7,175 @ $0.55 | 28,278 | Sep 17, 2024 |
| O'Neill Vincent | See Remarks | Sale | 5,556 @ $0.55 | 19,601 | Sep 17, 2024 |